Severe Asherman Syndrome: Pregnancy or Surrogacy Options?
At a Glance
Severe Asherman syndrome may not affect the ovaries, so IVF using your own eggs and a gestational carrier can preserve a genetic connection when the uterus cannot safely carry a pregnancy. Some patients can carry after treatment, but recurrence and placenta accreta risks require specialist care.
In this answer
4 sections
If your uterine lining does not recover sufficiently after surgery for severe Asherman syndrome, having a biological child is still a possibility for many patients. Asherman syndrome primarily damages the inside of the uterus (the endometrium) rather than the ovaries, meaning your ability to produce eggs is usually not directly affected [1] [2]. This allows many patients to undergo in vitro fertilization (IVF) to retrieve their own eggs, create embryos, and potentially use a gestational carrier. However, success depends on individual factors like age, ovarian reserve (your remaining egg supply), and egg quality.
How Your Ovaries Are Involved
Asherman syndrome involves intrauterine adhesions (scar tissue inside the uterus) and endometrial scarring [1] [2] [3]. Because it is a condition of the uterus, it generally does not harm your ovaries [1] [2].
This means that your doctor can still evaluate your ovarian reserve and, if appropriate, use IVF to retrieve eggs. However, creating a healthy embryo is not guaranteed; it relies on your age, sperm quality, and how the embryos develop in the lab. A reproductive endocrinologist can provide an individualized assessment of your chances of generating viable embryos.
Gestational Carriers as a Family-Building Option
If multiple surgeries fail to safely restore your uterine cavity, or if the risk of recurrence is too high, using a gestational carrier may be an option. In this process:
- You undergo IVF stimulation to retrieve your eggs.
- The eggs are fertilized in a laboratory using sperm from a partner or donor to create embryos.
- An embryo is transferred to a gestational carrier—a woman who carries the pregnancy but has no genetic link to the child.
While this path bypasses the damaged uterus and preserves your genetic connection, it is a complex process. It requires extensive medical screening, psychological counseling, independent legal contracts, and significant financial resources. Laws regarding gestational carriers also vary widely by location, so specialized legal and clinical guidance is essential.
Attempting Pregnancy in Your Own Uterus
Some patients with treated Asherman syndrome are able to carry a pregnancy. Research on IVF outcomes after treatment shows that some patients can achieve live births [4] [5]. Favorable signs during recovery include improved menstrual flow, a thicker endometrial lining, and minimal adhesions seen on a hysteroscopy (a camera examination of the inside of the uterus) [5].
However, there is no single endometrial thickness that guarantees a safe pregnancy. Severe Asherman syndrome has high rates of adhesion recurrence [6] [7] [8]. Patients who require multiple corrective surgeries to repair their uterus typically face lower live-birth rates compared to those without severe uterine factors [4]. Deciding when to stop surgical treatments requires balancing the chance of cavity improvement against the physical toll, the risk of recurrence, and the impact of age on your egg quality.
Important Risks If You Carry the Pregnancy
If you do become pregnant after treatment for severe Asherman syndrome, it is critical to know that prior uterine scarring increases the risk of serious maternal and fetal complications [6] [7] [8]. A major concern is placenta accreta spectrum, a condition where the placenta attaches too deeply to the uterine wall and does not separate normally after birth. This can lead to severe bleeding, the need for blood transfusions, preterm birth, or a hysterectomy [6] [7].
Because of these risks, you will need specialized care. This typically involves early consultation with a maternal-fetal medicine specialist (a high-risk obstetrician), detailed ultrasound monitoring of the placenta, and planning your delivery at a hospital equipped to handle complex complications [6] [7] [8]. Monitoring helps doctors detect and manage these risks, though it cannot eliminate them completely.
Common questions in this guide
Can I carry a pregnancy after treatment for severe Asherman syndrome?
Can I use my own eggs with a gestational carrier?
When should I consider a gestational carrier for severe Asherman syndrome?
What are the risks of carrying a pregnancy after severe Asherman syndrome?
How do I decide whether to have more uterine surgery or pursue a gestational carrier?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How and when should we evaluate my ovarian reserve before starting the IVF process?
- 2.Given my specific surgical history and hysteroscopy results, what is my realistic prognosis for safely carrying a pregnancy versus using a gestational carrier?
- 3.At what point in my treatment should we consider stopping uterine surgeries to prioritize my age and egg quality?
- 4.If I do carry a pregnancy, what is the exact plan for early placental assessment and maternal-fetal medicine monitoring?
- 5.Can you refer me to counselors, agencies, and legal experts experienced in gestational carrier arrangements in our specific jurisdiction?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (8)
- 1
CSF1-associated decrease in endometrial macrophages may contribute to Asherman's syndrome.
Liu D, Wang J, Zhao G, et al.
American journal of reproductive immunology (New York, N.Y. : 1989) 2020; (83(1)):e13191 doi:10.1111/aji.13191.
PMID: 31536655 - 2
Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?
Kelley AS, Giuliani E, Schon SB
Clinical obstetrics and gynecology 2020; (63(2)):320-326 doi:10.1097/GRF.0000000000000510.
PMID: 31815774 - 3
Asherman's syndrome: current perspectives on diagnosis and management.
Dreisler E, Kjer JJ
International journal of women's health 2019; (11()):191-198 doi:10.2147/IJWH.S165474.
PMID: 30936754 - 4
Treatment of intrauterine adhesions and subsequent pregnancy outcomes in an in vitro fertilization population.
Mortimer RM, Lanes A, Srouji SS, et al.
American journal of obstetrics and gynecology 2024; (231(5)):536.e1-536.e10 doi:10.1016/j.ajog.2024.05.026.
PMID: 38777163 - 5
A retrospective cohort study to examine factors affecting live birth after hysteroscopic treatment of intrauterine adhesions.
Zhao Y, Huang X, Huang R, et al.
Fertility and sterility 2024; (121(5)):873-880 doi:10.1016/j.fertnstert.2024.01.022.
PMID: 38246404 - 6
Review of Asherman syndrome and its hysteroscopic treatment outcomes: experience in a low-resource setting.
Siferih M, Gebre T, Hunduma F, et al.
BMC women's health 2024; (24(1)):99 doi:10.1186/s12905-024-02944-0.
PMID: 38326846 - 7
"The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.
Hanstede MMF, Veersema S, Emanuel MH, et al.
Fertility and sterility 2025; (124(5 Pt 2)):1104-1114 doi:10.1016/j.fertnstert.2025.06.027.
PMID: 40578664 - 8
Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.
Wang J, Movilla P, Morales B, et al.
Journal of minimally invasive gynecology 2021; (28(7)):1357-1366.e2 doi:10.1016/j.jmig.2020.10.004.
PMID: 33065259
This page is for informational purposes only and does not constitute medical advice. A reproductive endocrinologist and maternal-fetal medicine specialist can help you weigh pregnancy, IVF, and gestational carrier options.
Get notified when new evidence is published on Asherman syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.